Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
Findings seen for patients with type 2 diabetes during a five-year period
Interviews ID Factors Tied to COVID-19 Vaccine Hesitancy in Black Women
Mistrust in health care and government, concerns over vaccine safety and long-term effects among top factors
MEK Inhibition Beneficial for Children With Subset of Severe Hypertrophic Cardiomyopathy
Decrease in mortality, morbidity seen with trametinib for children with RASopathy-associated hypertrophic cardiomyopathy
Shorter Treatment Regimens Recommended for Tuberculosis
Four-month regimen recommended for drug-susceptible TB and six-month regimen recommended for drug-resistant TB
Polypill Treatment Offers High Value in Low-Income, Underserved Population
Polypill treatment estimated at $8,560 per QALY gained compared with usual care and had high value in 99 percent of simulations
FDA Adds Warning Label to RSV Vaccines Abrysvo and Arexvy
Postmarketing observation shows increased risk for Guillain-Barré syndrome for 42 days postvaccination
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
Reduction seen in risk for readmission, wound dehiscence, and hematoma, but no significant differences seen in rates of infection, bleeding
15.4 Percent of 0- to 35-Month-Olds Receive Invalid Vaccine Dose
Of children with minimum age or minimum interval invalid dose, almost 50 percent receive extra doses
AI Can Reliably Predict Efficacy of Immune Checkpoint Inhibitor Therapy
SCORPIO machine learning system can predict certain outcomes across diverse cancer types and health care settings
At-Home Disposal Kits Increase Self-Disposal Rates of Opioids
Findings seen for orthopedic surgery patients provided an opioid disposal kit at discharge
